Yulin Yu

723 total citations
23 papers, 579 citations indexed

About

Yulin Yu is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Yulin Yu has authored 23 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Biomedical Engineering. Recurrent topics in Yulin Yu's work include Immunotherapy and Immune Responses (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Immune cells in cancer (5 papers). Yulin Yu is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Nanoplatforms for cancer theranostics (7 papers) and Immune cells in cancer (5 papers). Yulin Yu collaborates with scholars based in China, United States and Japan. Yulin Yu's co-authors include Li Kong, Qian Hu, Mei Hu, Ting Yang, Shiping Yin, Kun Tu, Zhiping Zhang, Jianyu Zhang, Zhiping Zhang and Conglian Yang and has published in prestigious journals such as ACS Nano, Advanced Functional Materials and ACS Applied Materials & Interfaces.

In The Last Decade

Yulin Yu

20 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yulin Yu China 15 263 205 172 146 91 23 579
Yali Jiang China 12 347 1.3× 91 0.4× 79 0.5× 115 0.8× 36 0.4× 23 575
Zhiqiang Ma China 14 155 0.6× 252 1.2× 31 0.2× 73 0.5× 44 0.5× 32 529
Piao Huang China 7 144 0.5× 542 2.6× 125 0.7× 45 0.3× 24 0.3× 13 887
Fengfeng Xiao China 10 339 1.3× 148 0.7× 101 0.6× 139 1.0× 21 0.2× 17 575
Yuhang Mao China 12 200 0.8× 170 0.8× 37 0.2× 49 0.3× 29 0.3× 25 453
Xiaohan Zhou China 13 314 1.2× 174 0.8× 70 0.4× 101 0.7× 6 0.1× 26 556
Asiri Ediriwickrema United States 12 142 0.5× 238 1.2× 52 0.3× 119 0.8× 3 0.0× 22 628
Rongrong Wu China 10 123 0.5× 122 0.6× 22 0.1× 62 0.4× 46 0.5× 33 430
Cong Huang China 10 234 0.9× 149 0.7× 118 0.7× 96 0.7× 2 0.0× 24 463
Hirofumi Ono Japan 9 103 0.4× 158 0.8× 73 0.4× 74 0.5× 3 0.0× 21 499

Countries citing papers authored by Yulin Yu

Since Specialization
Citations

This map shows the geographic impact of Yulin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulin Yu more than expected).

Fields of papers citing papers by Yulin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulin Yu. The network helps show where Yulin Yu may publish in the future.

Co-authorship network of co-authors of Yulin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yulin Yu. A scholar is included among the top collaborators of Yulin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulin Yu. Yulin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yang, Yulin Yu, Bin Xia, et al.. (2025). Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generation. Journal of Controlled Release. 382. 113658–113658.
2.
Yu, Yulin, et al.. (2025). Peptide based vesicles for cancer immunotherapy: design, construction and applications. Frontiers in Immunology. 16. 1609162–1609162.
3.
Zhang, Fangming, Siyu Zhao, Yulin Yu, et al.. (2025). Pathogen‐Mimicking Cancer Vaccine with Self‐Generated dsRNA Potentiates Innate Immunity Against Colon Cancer. Advanced Functional Materials. 35(46).
4.
Hu, Qian, et al.. (2024). Colon Targeting pH‐Responsive Coacervate Microdroplets for Treatment of Ulcerative Colitis. Small. 20(33). e2311890–e2311890. 19 indexed citations
5.
Li, Xiaonan, Qi Qiao, Qian Hu, et al.. (2024). Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome. ACS Nano. 18(2). 1658–1677. 23 indexed citations
6.
Yu, Yulin, Yang Li, Xianya Qin, et al.. (2024). Self-generated double-stranded RNA for enhancing tumor immunotherapy and metastasis inhibition. Nano Today. 55. 102173–102173. 5 indexed citations
7.
Hu, Qian, Xiao‐Nan Li, Mengmeng Wang, et al.. (2023). Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemia. Journal of Controlled Release. 365. 176–192. 15 indexed citations
8.
Li, Yang, Dan Zhang, Yulin Yu, et al.. (2023). De novo engineering of nanoformulation from traditional Chinese medicine mixtures for psoriasis. Nano Research. 16(4). 5279–5291. 8 indexed citations
9.
Yu, Yulin, Yang Li, Qian Hu, et al.. (2022). Boosting B Cell and Macrophage‐Mediated Humoral Immunity with Fusion Nanovesicles for Triple‐Negative Breast Cancer Combined Therapy. Advanced Healthcare Materials. 12(6). e2202209–e2202209. 16 indexed citations
10.
Qiao, Qi, Xiong Liu, Kexin Cui, et al.. (2022). Hybrid Biomimetic Nanovesicles to Drive High Lung Biodistribution and Prevent Cytokine Storm for ARDS Treatment. ACS Nano. 16(9). 15124–15140. 28 indexed citations
11.
Tu, Kun, Yulin Yu, Yi Wang, et al.. (2021). Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade. ACS Applied Materials & Interfaces. 13(33). 39003–39017. 51 indexed citations
12.
Yin, Shiping, et al.. (2020). Flexural Durability and Chloride Diffusion Equation of TRC-Strengthened Beams under a Chloride Environment. KSCE Journal of Civil Engineering. 24(6). 1868–1880. 5 indexed citations
13.
Hu, Mei, Jianyu Zhang, Yulin Yu, et al.. (2020). Injectable Liquid Crystal Formation System for Reshaping Tumor Immunosuppressive Microenvironment to Boost Antitumor Immunity: Postoperative Chemoimmunotherapy. Small. 16(50). e2004905–e2004905. 21 indexed citations
14.
Hu, Qian, Lihuan Shang, Mengmeng Wang, et al.. (2020). Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy. Advanced Healthcare Materials. 9(10). e1901858–e1901858. 48 indexed citations
15.
Yin, Shiping, et al.. (2019). Research on chloride diffusion and flexural behavior of beams strengthened with TRC subjected to dry-wet cycles. Construction and Building Materials. 229. 116906–116906. 21 indexed citations
16.
Xu, Chenfeng, Yulin Yu, Yu Sun, et al.. (2019). Transformable Nanoparticle‐Enabled Synergistic Elicitation and Promotion of Immunogenic Cell Death for Triple‐Negative Breast Cancer Immunotherapy. Advanced Functional Materials. 29(45). 74 indexed citations
17.
Yu, Yulin, et al.. (2019). Bending performance of TRC-strengthened RC beams with secondary load under chloride erosion. Journal of Central South University. 26(1). 196–206. 10 indexed citations
18.
Xu, Chenfeng, Yu Sun, Yan Qi, et al.. (2018). Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis. Journal of Controlled Release. 284. 224–239. 21 indexed citations
19.
Yin, Shiping, Yulin Yu, & Yunping Xi. (2018). Flexural performance of TRC-strengthened RC beam under chloride environment. Anti-Corrosion Methods and Materials. 65(5). 444–450. 6 indexed citations
20.
Yin, Shiping, et al.. (2016). Research on the flexural performance of RC beams strengthened with TRC under the coupling action of load and marine environment. Construction and Building Materials. 132. 251–261. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026